I agree that this site is using cookies. You can find further informations here.
X
Zhu, Baojin
245  results:
Search for persons X
?
1

Six-Month Real-World Study to Assess the Effectiveness of I..:

Lebwohl, Mark ; Strober, Bruce ; Schrader, Amy...
Drugs - Real World Outcomes.  , 2024
Link: https://doi.org/10.1007/..
 
?
2

Satisfaction with the Injection Experience of a New, Citrat..:

Chabra, Sanjay ; Birt, Julie ; Bolce, Rebecca...
Advances in Therapy.  41 (2024)  4 - p. 1672-1684 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Achievement of the National Psoriasis Foundation Treatment ..:

Gottlieb, Alice ; Burge, Russel ; Malatestinic, William...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  3 - p. s201 , 2023
Link: https://doi.org/10.25251..
 
?
4

Comparison of Real-World Costs, Healthcare Resource Utiliza..:

Blauvelt, Andrew ; Shi, Nianwen ; Somani, Najwa...
Clinical Drug Investigation.  43 (2023)  3 - p. 185-196 , 2023
Link: https://doi.org/10.1007/..
 
?
5

6-Month Real World Study to Assess the Effectiveness of Ixe..:

Lebwohl, Mark ; Strober, Bruce ; Schrader, Amy...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  6 - p. s232 , 2023
Link: https://doi.org/10.25251..
 
?
6

Development of Psoriasis Assessment Tools Among Patients in..:

Gulliver, Wayne P. ; See, Kyoungah ; Zhu, Baojin...
Journal of Psoriasis and Psoriatic Arthritis.  8 (2023)  2 - p. 74-82 , 2023
Link: https://doi.org/10.1177/..
 
?
7

Real-world effectiveness of ixekizumab in mild, moderate, a..:

Gottlieb, Alice ; Burge, Russel ; Malatestinic, William...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  3 - p. s202 , 2023
Link: https://doi.org/10.25251..
 
?
8

Letter to the Editor: Response to Fitzgerald T et al. Long-..:

Blauvelt, Andrew ; Garrelts, Alyssa ; Malatestinic, William...
Dermatology and Therapy.  13 (2023)  11 - p. 2911-2916 , 2023
Link: https://doi.org/10.1007/..
 
?
9

43015 Ixekizumab real-world effectiveness at 24 weeks in pa..:

Gottlieb, Alice ; Burge, Russel ; Malatestinic, William...
Journal of the American Academy of Dermatology.  89 (2023)  3 - p. AB185 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Ixekizumab Real-World Effectiveness at 24 Weeks in Patients..:

Gottlieb, Alice B. ; Burge, Russel ; Malatestinic, William N....
Dermatology and Therapy.  13 (2023)  8 - p. 1831-1846 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Real-World Biologic Adherence, Persistence, and Monotherapy..:

Leonardi, Craig ; Zhu, Baojin ; Malatestinic, William N....
Advances in Therapy.  39 (2022)  7 - p. 3214-3224 , 2022
Link: https://doi.org/10.1007/..
 
?
12

Treatment Goals for Psoriasis as Measured by Patient Benefi..:

Armstrong, April ; Edson-Heredia, Emily ; Zhu, Baojin...
Advances in Therapy.  39 (2022)  6 - p. 2657-2667 , 2022
Link: https://doi.org/10.1007/..
 
?
13

Outcomes in Ixekizumab Patients Following Exposure to Secuk..:

Lockshin, Benjamin ; Harrison, Ryan W. ; McLean, Robert R....
Dermatology and Therapy.  12 (2022)  12 - p. 2797-2815 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Healthcare Costs Among Patients with Psoriasis Treated with..:

Blauvelt, Andrew ; Shi, Nianwen ; Burge, Russel...
PharmacoEconomics - Open.  6 (2022)  6 - p. 871-880 , 2022
Link: https://doi.org/10.1007/..
 
?
15

Improvement of Functioning and Health With Ixekizumab in th..:

Walsh, Jessica A. ; Magrey, Marina N. ; Baraliakos, Xenofon...
Arthritis Care & Research.  74 (2022)  3 - p. 451-460 , 2022
Link: https://doi.org/10.1002/..
 
1-15